Peer-influenced content. Sources you trust. No registration required. This is HCN.

ReachMDSerotonin Booster Increases Functional Brain Connectivity

Probing the Pro-Cognitive Potential of Prucalopride: An Eye-Opening Inquiry into Cognitive Enhancement


In an intriguing development in neuropsychiatric research, scientists have examined the neurological impacts of prucalopride, a laxative known to activate serotonin receptors, on cognitive function and mood regulation.

Key Points:

  • Serotonin receptors, especially 5-HT4-type receptors, are key targets for antidepressants and influence cognitive function and mood regulation.
  • Prucalopride, a selective agonist of the 5-HT4 serotonin receptor, has shown promising results in enhancing cognitive function.
  • A study on 50 healthy adults found increased functional connectivity in cognitive networks in the prucalopride group as compared to a placebo group.

Additional Points:

  • There was increased functional connectivity between major cognitive networks, specifically the central executive network and regions of the ACC and lateral occipital cortex.
  • A decrease in functional connectivity was observed in the default mode network in participants taking prucalopride.
  • Participants on prucalopride scored higher in cognitive tests on the day of scanning than those on placebo, suggesting this could be a ‘signature’ of a cognition-improving drug.

Conclusion:

  • Prucalopride’s effects on the brain’s cognitive networks could signify its potential as a treatment for depression and cognitive impairment, warranting further research into 5-HT4 serotonin receptor-targeting drugs.

Psychiatry Latest Posts

“Our previous studies on prucalopride demonstrated that even at low clinical doses it can improve cognition and memory in healthy volunteers. This latest research provides a neurological mechanism by which this might occur.”

Angharad de Cates, PhD, MRCPsych
University of Oxford
The Healthcare Communications Network is owned and operated by IQVIA Inc.

Click below to leave this site and continue to IQVIA’s Privacy Choices form